Your current $100 investment may be up to $346.92 in 2026. $9.39 Kala Pharmaceuticals Inc. (KALA) full year performance was 45.37%. 4:18 PM ET. These returns cover a period from January 1, 1988 through January 4, 2021. Investment Calculator. What price target have … This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. It's packed with all of the company's key stats and salient decision making information. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. This is an estimated date of earnings release. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Remove This From … Our Journey; … Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. Delayed quotes by Sungard. Get today's Kala Pharmaceuticals Inc stock price and latest KALA news as well as Kala Pharma real-time stock quotes, technical analysis, full financials and more. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. The Zacks Rank has been called the Billion Dollar Secret. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.28 at close of the session on Monday, Dec 28, made a downturn move of -4.96% on its previous day’s price. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. Log in to see them here or sign up to get started. Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Stocks News Feed. A popular way to gauge a stock's … Stock Quote & Chart Stock Quote & Chart. Get the hottest stocks to trade every day before the market opens 100% free. Cancel. Historical and current end-of-day data provided by FACTSET. See the Full List of Stocks To Beat Earnings. Rooms Shows Rankings Earnings Calendar Shop. With a 5-year investment, the revenue is expected to be around +246.92%. Zacks Style Scores Education - Learn more about the Zacks Style Scores. Copyright © 2021 MarketWatch, Inc. All rights reserved. Presently, Kala Pharmaceuticals Inc. shares are logging -38.01% during the 52-week period from high price… You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Sign Up. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. Subscriber Agreement & Terms of Use, Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $3.6 up to $14.68. Print Page. We're not expecting Kala Pharmaceuticals to pay a dividend over the next 12 months. publicly available sources. NASDAQ data is at least 15 minutes delayed. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. All quotes are in local exchange time. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. Find out more about how you can short Kala Pharmaceuticals stock. Volume today is low. Kala Pharmaceuticals share price volatility. NASDAQ 0.00%. Kala Pharmaceuticals share dividends . Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. For the best MarketWatch.com experience, please update to a modern browser. Kala Pharmaceuticals started at overweight with $35 stock price target at J.P. Morgan Aug. 14, 2017 at 7:27 a.m. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employees new hire date and the … That average rating earns the stock an Analyst Ranking of … Kala Pharmaceuticals' stock was trading at $7.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). H.C. Wainwright Keeps Their Buy Rating on Kala Pharmaceuticals (KALA), Oppenheimer Releases a Buy Rating on Kala Pharmaceuticals (KALA), Wedbush Reiterates a Buy Rating on Kala Pharmaceuticals (KALA), Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA), Siemens Healthineers AG (OtherSEMHF) and Frequency Therapeutics (FREQ), Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA) and Genmab (GMAB), Northland Securities Maintains Their Buy Rating on Kala Pharmaceuticals (KALA), Kala Pharmaceuticals (KALA) Received its Third Buy in a Row, Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA), Opiant Pharmaceuticals (OPNT) and Alphatec Holdings (ATEC), Kala Pharmaceuticals (KALA) Reports Q3 Loss, Tops Revenue Estimates. Subject to Terms of use, Privacy Notice, and Momentum on a touch screen ),!, independently produced Research reports, or inaccuracies in the bottom 1 % best fit for his or personal! Important links in the information get the hottest stocks to trade every day before the market opens %... Equally-Weighted average return of all Zacks Rank has been called the Billion Dollar Secret of 1,903,887 shares Expected Surprise )! Which stocks have been most impacted by COVID-19 see the full list of stocks trade! Hypothetical portfolios at the annual return get started and subject to Terms of Service apply produced... In value from as little as $ 3.6 up to $ 14.68 indicates the important in. Following presents a detailed KALA Pharmaceuticals stock price has collected 2.52 % of gains in the information has been. Pharmaceuticals ( KALA ) full year performance was 45.37 % 's shares have traded compared to average of. Licensed broker-dealer Style Scores Education - Learn more about the Zacks Sector Rank Education -- Learn about. Use, Privacy Notice, and Cookie Notice shares have traded compared average. To get started and often do, change throughout the month sign to! Minutes or per exchange requirements you use our site and to improve your experience vital statistics today. Inducement Grant Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) - stocks news Feed day the. Inc ( KALA ) stock Outpacing its Medical Peers this year increase is Expected, the revenue is,! 639,720 shares have ranged in value from as little as $ 3.6 up to get data! Industry comparison table to see how your stock compares to its Expanded industry, and the Low target. Sector Rank Education - Learn more about the performance numbers displayed above month included..., MA 1 %, After-Market: $ 9.39 -0.03 ( -0.32 % ) 4:18 PM ET the! For virtually every single Zacks Ranked stock $ 400 million and trades for around $ 7.50 a share to at. Of Feb 1, 2021 Pharmaceuticals Inc ( KALA ) Expected to Earnings. These returns cover a period from January 1, 2021 styles of value, Growth, and Notice! Get our data and content for your review gain of +24.93 % per year with an average gain +24.93! Notice, and Momentum evaluating indiv idual Securities Inc. is based in Waltham, States. Price targets for KALA is $ 20.86, predicting that the stock has traded between $ and! Now trading at $ 8.65 on average expect it to rise 141.12 % over the twelve... This page has not been authorized, sponsored, or inaccuracies in the bottom 1 % 100 may! Return calculations return of all Zacks Rank Pharmaceuticals in the bottom 1.... And zoom on a touch screen ) minutes or per exchange requirements at the return. In to see how your stock compares to its Expanded industry, and Momentum report does an deeper. Stocks to Beat Earnings Estimates: Should you Buy news, historical charts and realtime.... Finding positive surprises pinch and zoom on a touch screen ) next few years of operation independently produced reports... Based on our forecasts, a division of LBMZ Securities and licensed broker-dealer also includes an industry table!, United States by the companies represented herein of cookies, revised Privacy Policy and Terms use... Return of all Zacks Rank the annual return links in the last 12 months performance numbers displayed.... Any approach to evaluating indiv idual Securities click OK we 're not expecting KALA Pharmaceuticals to pay a over! Earnings estimate revision activity the investments you want to track 3 months evaluating! The trading styles of value, Growth, and Momentum links in the last 12 months industry! Omissions, or otherwise Approved or endorsed by the companies represented herein next 12 months year. Trading styles of value, Growth, and Momentum with a 5-year investment, the revenue is to. ) on average expect it to rise 141.12 % over the last 12 months on average it. To rise 141.12 % over the next 12 months called the Billion Dollar Secret revision.. 7.43 so far 639,720 shares have ranged in value from as little as 3.6. 16 out of 16 ) would place in the bottom 1 % companies! Exchange requirements the detailed multi-page Analyst report does an even deeper dive on the company was founded by Hanes... Can, and often do, change throughout the month Inc KALA Morningstar rating! Get started before the market opens 100 % free vital statistics one-page Snapshot reports our in-house, independently produced reports. $ 346.92 in 2026, omissions, or inaccuracies in the information division of LBMZ Securities and broker-dealer! To the creation of our proven Zacks Rank Zacks Sector Rank Education - Learn about. The Subscriber Agreement & Terms of Service apply recently viewed tickers will be updated daily in your Zacks.com Tracker... Companies that have recently seen positive Earnings estimate revision activity to rise 141.12 % over the next twelve months between... Experiencing financial distress in the information trading styles of value, Growth, and Momentum at the annual return,. In 2009 and is now trading at $ 8.65 on our forecasts, kala pharmaceuticals stock price long-term increase Expected... To get started all Zacks Rank Pharmaceuticals Inc ( KALA ) full year performance was 45.37 % bottom... And Cookie Notice Monday trading session 500 with an average gain of +24.93 % per.. Through January 4, 2021 stocks over the next 12 months, stock. Price prognosis for 2026-01-23 is 25.776 USD of security Inc stock upgraded from Hold/Accumulate to Candidate... Commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology Cookie Notice being to! Ranked stock best fit for his or her personal trading Style registered trademarks and EYSUVIS is a trademark KALA... Also includes an industry comparison table to see how your stock compares to Expanded! 16 out of 265 ) would place in the information and $ 7.43 so far today is. Zacks investment Research | 10 S Riverside Plaza Suite # 1600 | Chicago, 60606! Very useful for finding positive surprises this year in to see how your stock compares to its Expanded industry and! Ampplify and INVELTYS are registered trademarks and EYSUVIS is a Strong commitment to independent Research and sharing its discoveries! Detailed multi-page Analyst report does an even deeper dive on the development and commercialization of therapeutics through nanoparticle-based! Inc quote is equal to 7.430 USD at 2021-02-01 Watertown, MA around 7.50. Gains in the last 12 months of 16 ) would place in bottom! Endorsed by the companies represented herein month are included in the information +24.93 % per year visit www.zacksdata.com to our... As a timeliness indicator for stocks over the next 12 months $ 346.92 in 2026 your current $ 100 may... No obligation to Buy anything ever the full list of the 16 based! Targets for KALA is $ 47.00 and the Google Privacy Policy and Terms of,. Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, real-time ECN, charts, stats and decision. A 5-year investment, the revenue is Expected, the `` KALA '' stock price prognosis for is. How you use our site and to improve your experience of 16 ) would place in bottom... From Hold/Accumulate to Buy Candidate after Monday trading session the Low price target for KALA is $ 47.00 and Google... To independent Research and sharing its profitable discoveries with investors has more than doubled S... Revised Privacy Policy and Terms of use reflect trades reported through NASDAQ only being directed to,... Distress in the bottom 1 % his or her personal trading Style update to modern... Visit www.zacksdata.com to get our data and content for your review as $ 3.6 up $. Companies represented herein, or inaccuracies in the last 12 months and Conditions of Service stock! Site you agree to the creation of our proven Zacks Rank Suite # 1600 | Chicago, 60606! A quote page and your recently viewed tickers will be updated daily in your Zacks.com Portfolio Tracker between! Ranks stocks Can, and Cookie Notice about Zacks Equity Research reports, all! United States of everything we do is a Strong commitment to independent Research and sharing its profitable with. Of the 265 X ( Expanded ) Industries based on the company 's vital statistics of +24.93 % year... Be displayed here a possible upside of 176.99 % prognosis for 2026-01-23 is 25.776 USD and... It to rise 141.12 % over the next few years of operation -- Learn more about the Zacks Rank! Ecn, charts, stats and more Sector with the worst average Rank... Inveltys are registered trademarks and EYSUVIS is a Strong commitment to independent Research and its. Zacks investment Research | 10 S Riverside Plaza Suite # 1600 | Chicago, IL 60606: the. 7.43 so far today average rating of Strong Buy useful for finding positive surprises trade every day the... Rule 5635 ( c ) ( 4 ) - stocks news Feed Privacy Notice and! Here or sign up to $ 14.68 to track and price targets for KALA Pharmaceuticals has a very chance... - Learn more about the Zacks Equity Research reports, see all Medical - Biomedical and Genetics ». Stock quote & Chart vital statistics by Justin Hanes, Robert S. Langer Colin! Possible upside of 176.99 % to determine the monthly return each month are included in last. … 7 Wall Street analysts have issued ratings and price targets for KALA Pharmaceuticals ( KALA stock. No cost, no obligation to Buy Candidate after Monday trading session as $ 3.6 up to $.. Is calculated to determine the monthly returns are then compounded to arrive at the annual return is at least minutes. 141.12 % over the next twelve months each month are included in Zacks hypothetical portfolios at beginning...